Log in to save to my catalogue

EditForce et Mitsubishi Tanabe Pharma concluent un accord de licence

EditForce et Mitsubishi Tanabe Pharma concluent un accord de licence

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2684871626

EditForce et Mitsubishi Tanabe Pharma concluent un accord de licence

About this item

Full title

EditForce et Mitsubishi Tanabe Pharma concluent un accord de licence

Publisher

New York: PR Newswire Association LLC

Journal title

PR Newswire Europe (French), 2022

Language

French

Publication information

Publisher

New York: PR Newswire Association LLC

More information

Alternative Titles

Full title

EditForce et Mitsubishi Tanabe Pharma concluent un accord de licence

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_2684871626

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2684871626

How to access this item